P. Comella - Concepedia

Author

P. Comella

Also Known As

E. Dorval, G D'Aiuto, Gianluigi Ferretti, P Comella, P. Comella, P. Commella, Pasquale Comella, on behalf of the Gruppo Oncologico Campano

101

Publications

Citations

H-Index

Concepts

All Affiliations

Tumour Institute of Tuscany University of Palermo University of Sassari Ospedale S.Gennaro University of Cagliari

About

P. Comella is an author at Tumour Institute of Tuscany specializing in cancer therapeutics, medicine, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	22	533
2	Health Sciences	2	2	30
3	Gastroenterology	2	2	37
4	Natural Sciences	1	1	11
5	Biochemistry	1	1	11

P. Comella

Publications

772

Citations

H-Index

Page 1

	Year	Citations
Preoperative weekly cisplatin–epirubicin–paclitaxel with G-CSF support in triple-negative large operable breast cancer G. Frasci, P. Comella, Massimo Rinaldo, Annals of Oncology G-csf SupportSurgical OncologyOncologyBreast OncologyMedicine	2009	93
Gemcitabine with either paclitaxel or vinorelbine vs paclitaxel or gemcitabine alone for elderly or unfit advanced non-small-cell lung cancer patients P. Comella, G. Frasci, P. Carnicelli, British Journal of Cancer	2004	69
Efficacy of the combination of cisplatin with either gemcitabine and vinorelbine or gemcitabine and paclitaxel in the treatment of locally advanced or metastatic non-small-cell lung cancer: a phase III randomised trial of the Southern Italy Cooperative Oncology Group (SICOG 0101) P. Comella, Gianfranco Filippelli, G. De Cataldis, Annals of Oncology OncologyMedicinePhase IiiMetronomic TherapyBronchial Neoplasm	2006	47
Cisplatin-topotecan-paclitaxel weekly administration with G-CSF support for ovarian and small-cell lung cancer patients: A dose-finding study G. Frasci, N. Panza, P. Comella, Annals of Oncology G-csf SupportDose-finding StudyMedicineCancer ManagementGynecology	1999	39
Biweekly oxaliplatin, raltitrexed, 5-fluorouracil and folinic acid combination chemotherapy during preoperative radiation therapy for locally advanced rectal cancer: a phase I–II study Antonio Avallone, Paolo Delrio, Cesare Guida, British Journal of Cancer	2006	36
Docetaxel and cisplatin in locally advanced or metastatic squamous-cell carcinoma of the head and neck: A phase II study of the Southern Italy Cooperative Oncology Group (SICOG) Francesco Caponigro, Elena Massa, Luigi Manzione, Annals of Oncology Metastatic Squamous-cell CarcinomaMedicinePathologyPhase Ii StudyNeck Pathology	2001	34
Oxaliplatin plus raltitrexed and leucovorin-modulated 5-fluorouracil i.v. bolus: a salvage regimen for colorectal cancer patients P. Comella, Rossana Casaretti, E. Crucitta, British Journal of Cancer	2002	30
Cisplatin, gemcitabine and vinorelbine in locally advanced or metastatic non-small-cell lung cancer: A phase I study G. Frasci, N. Panza, P. Comella, Annals of Oncology MedicinePathologyBronchial NeoplasmCancer TreatmentOncology	1997	30
Preoperative weekly cisplatin, epirubicin, and paclitaxel (PET) improves prognosis in locally advanced breast cancer patients: an update of the Southern Italy Cooperative Oncology Group (SICOG) randomised trial 9908 G. Frasci, Giuseppe D’Aiuto, P. Comella, Annals of Oncology Breast OncologyOncologyCancer ManagementBreast CancerTrial 9908	2009	29
A weekly regimen of cisplatin, paclitaxel and topotecan with granulocyte-colony stimulating factor support for patients with extensive disease small cell lung cancer: a phase II study G. Frasci, G.P. Nicolella, P. Comella, British Journal of Cancer	2001	28

Page 1